Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
An 8-Week, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dosage Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder https://www.kusajili.fr:443/Trial/LfsJ0IAYi0i0KUXcnkgAxg%24an-8-week-double-blind-placebo-controlled-parallel-group-fixed-dosage-study-to-evaluate-the-efficacy-and-safety-of-armodafinil-
I have read and accept the terms of use of the site and the Privacy Policy
Send your message